These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21095627)

  • 21. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
    Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of point-of-care oral ivabradine for cardiac computed tomography.
    Guler EC; Yam Y; Jia K; El Mais H; Hossain A; Chow BJW; Small GR
    J Cardiovasc Comput Tomogr; 2021; 15(3):226-231. PubMed ID: 33039320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-source computed tomography coronary angiography: influence of obesity, calcium load, and heart rate on diagnostic accuracy.
    Alkadhi H; Scheffel H; Desbiolles L; Gaemperli O; Stolzmann P; Plass A; Goerres GW; Luescher TF; Genoni M; Marincek B; Kaufmann PA; Leschka S
    Eur Heart J; 2008 Mar; 29(6):766-76. PubMed ID: 18292596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of dual-source CT coronary angiography: The effect of average heart rate, heart rate variability, and calcium score in a clinical perspective.
    Zhang LJ; Wu SY; Wang J; Lu Y; Zhang ZL; Jiang SS; Zhou CS; Lu GM
    Acta Radiol; 2010 Sep; 51(7):727-40. PubMed ID: 20707657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of pre-scan beta-blockade and impact of heart rate on image quality in patients undergoing coronary multidetector computed tomography angiography.
    Shapiro MD; Pena AJ; Nichols JH; Worrell S; Bamberg F; Dannemann N; Abbara S; Cury RC; Brady TJ; Hoffmann U
    Eur J Radiol; 2008 Apr; 66(1):37-41. PubMed ID: 17587526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective and retrospective ECG-gating for CT coronary angiography perform similarly accurate at low heart rates.
    Stolzmann P; Goetti R; Baumueller S; Plass A; Falk V; Scheffel H; Feuchtner G; Marincek B; Alkadhi H; Leschka S
    Eur J Radiol; 2011 Jul; 79(1):85-91. PubMed ID: 20079993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
    J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ivabradine therapy to unmask heart rate-independent effects of β-blockers on pulse wave reflections.
    Fischer-Rasokat U; Honold J; Lochmann D; Liebetrau C; Leick J; Hamm C; Fichtlscherer S; Möllmann H; Spyridopoulos I
    Clin Res Cardiol; 2014 Jun; 103(6):487-94. PubMed ID: 24535377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Ivabradine on Heart Rate and Duration of Exercise in Patients With Mild-to-Moderate Mitral Stenosis: A Randomized Comparison With Metoprolol.
    Saggu DK; Narain VS; Dwivedi SK; Sethi R; Chandra S; Puri A; Saran RK
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):552-4. PubMed ID: 25636072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.
    Tavazzi L; Swedberg K; Komajda M; Böhm M; Borer JS; Lainscak M; Robertson M; Ford I;
    Int J Cardiol; 2013 Dec; 170(2):182-8. PubMed ID: 24225201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and safety profile of ivabradine in healthy Chinese men: a phase I, randomized, open-label, increasing single- and multiple-dose study.
    Jiang J; Tian L; Huang Y; Li Y; Xu L
    Clin Ther; 2013 Dec; 35(12):1933-45. PubMed ID: 24332196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients.
    Nerla R; Di Franco A; Milo M; Pitocco D; Zaccardi F; Tarzia P; Sarullo FM; Villano A; Russo G; Stazi A; Ghirlanda G; Lanza GA; Crea F
    Heart; 2012 Dec; 98(24):1812-6. PubMed ID: 23086971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of radiation dose and heart rate in dual-source computed tomography coronary angiography.
    Laspas F; Tsantioti D; Roussakis A; Kritikos N; Efthimiadou R; Kehagias D; Andreou J
    Acta Radiol; 2011 Apr; 52(3):273-7. PubMed ID: 21498362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Status of β-blocker use and heart rate control in Chinese patients with stable coronary artery disease].
    Sun Y; Yu J; Hu D;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jan; 44(1):19-26. PubMed ID: 26813548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
    Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
    Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
    Dillinger JG; Maher V; Vitale C; Henry P; Logeart D; Manzo Silberman S; Allée G; Levy BI
    Hypertension; 2015 Dec; 66(6):1138-44. PubMed ID: 26418022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
    Böhm M; Swedberg K; Komajda M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):886-94. PubMed ID: 20801495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart rate-reducing therapy with add-on ivabradine and bisoprolol before coronary computed tomographic angiography in a fast-track ambulatory setting.
    Muster V; Wallner M; Schmidt A; Kapl M; von Lewinski F; Rainer P; Reittner P; Tillich M; Brader P; Szolar DH; von Lewinski D
    J Int Med Res; 2018 Jun; 46(6):2249-2257. PubMed ID: 29614895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.